+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

From
From
Stem Cell Manufacturing Market Report 2025 - Product Thumbnail Image

Stem Cell Manufacturing Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Neurofibrosarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Neurofibrosarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
From
Stem Cell Therapy Market Report 2025 - Product Thumbnail Image

Stem Cell Therapy Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 90 Pages
  • Global
From
From
From
Industry Snapshots: Japan Pharmaceuticals - Product Thumbnail Image

Industry Snapshots: Japan Pharmaceuticals

  • Newsletter
  • May 2025
  • 75 Pages
  • Japan
From
Company Snapshots: Japan Pharmaceutical - Product Thumbnail Image

Company Snapshots: Japan Pharmaceutical

  • Newsletter
  • May 2025
  • 35 Pages
  • Japan
From
From
From
From
Ewings Sarcoma Treatment Market 2025-2029 - Product Thumbnail Image

Ewings Sarcoma Treatment Market 2025-2029

  • Report
  • December 2024
  • 197 Pages
  • Global
From
From
From
Loading Indicator